ANG Lifesciences India Ltd. benchmarking: Perfomance to industry peers

Financial

	ANG Lifesciences	Sandu Pharmaceutical	Chandra Bhagat Pharm
Operational Metrics
Financials
5 yr Average ROE	3.78 %	3.72 %	3.03 %
5yr average Equity Multiplier	3.3	1.33	2.92
5yr Average Asset Turnover Ratio	0.77	1.23	1.46
5yr Avg Net Profit Margin	-2.26 %	2.27 %	0.71 %
Price to Book	0.59	0.79	1.07
P/E	0.0	21.04	37.12
5yr Avg Cash Conversion Cycle	70.26 Days	48.49 Days	123.14 Days
Inventory Days	107.37 Days	74.6 Days	97.15 Days
Days Receivable	274.82 Days	26.14 Days	158.67 Days
Days Payable	235.98 Days	72.73 Days	38.34 Days
5yr Average Interest Coverage Ratio	1.81	28.2	1.63
5yr Avg ROCE	15.08 %	5.33 %	10.9 %
5yr Avg Operating Profit Margin	7.68 %	3.77 %	1.16 %
5 yr average Debt to Equity	0.97	0.0	0.76
5yr CAGR Net Profit	n/a	0.39 %	35.25 %
5yr Average Return on Assets	1.04 %	2.79 %	1.04 %
Shareholdings
Promoter Holding	70.6 %	37.79 %	72.19 %
Share Pledged by Promoters	44.88 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.55 %	-12.64 %	1.77 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0